专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明公开

EP2303909A4 IQGAP3 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME 审中-公开
标题翻译： IQGAP3表位肽和疫苗含
公开(公告)号：EP2303909A4
公开(公告)日：2012-10-31
申请号：EP09762266
申请日：2009-06-10
申请人： ONCOTHERAPY SCIENCE INC
发明人： TSUNODA TAKUYA , OHSAWA RYUJI , YOSHIMURA SACHIKO , WATANABE TOMOHISA
IPC分类号： C07K4/12 , A61K39/00 , A61P35/00 , C07K7/06 , C07K14/74 , C12N15/09 , C12N5/06
CPC分类号： C07K14/4722 , A61K39/0011 , C07K7/06 , C07K14/4706

2. 发明公开

EP2314671A4 METHOD FOR CULTURE OF STEM CELL 有权转让
标题翻译：干细胞培养方法
公开(公告)号：EP2314671A4
公开(公告)日：2012-07-18
申请号：EP09758437
申请日：2009-06-05
申请人： RIKEN
发明人： SASAI YOSHIKI , WATAYA TAKAFUMI , EIRAKU MOTOTSUGU
IPC分类号： C12N5/0797 , C12N5/06
CPC分类号： C12N5/0623 , C12N2501/33 , C12N2501/415 , C12N2501/42 , C12N2501/70 , C12N2506/02

3. 发明公开

EP2250497A4 CELL PROCESSING AND/OR ENRICHMENT METHODS 有权
标题翻译：细胞处理和/或浓缩过程
公开(公告)号：EP2250497A4
公开(公告)日：2011-08-24
申请号：EP09712569
申请日：2009-02-18
申请人： GENETIC TECHNOLOGIES LTD
发明人： MANTZARIS DEBBIE , ALLMAN RICHARD
IPC分类号： G01N33/483 , C12N5/073 , C12Q1/68 , C12N5/08 , C12N5/06
CPC分类号： C12N5/0603

4. 发明公开

EP2190979A4 ENHANCEMENT OF TRANSGENE EXPRESSION FROM VIRAL-BASED VACCINE VECORS BY EXPRESSION OF SUPPRESSORS OF THE TYPE I INTERFERON RESPONSE 审中-公开
标题翻译：改进疫苗载体的转基因表达对BASIS按类别划分的抑制器病毒表达我干扰素反应
公开(公告)号：EP2190979A4
公开(公告)日：2011-08-24
申请号：EP08798942
申请日：2008-08-29
申请人： AERAS GLOBAL TB VACCINE FOUNDATION
发明人： SADOFF JERALD C , FULKERSON JOHN , FAKRUDDIN-JAMILUDDIN MOHAMAD , STONE MICHELE R , ANANTHA RAVI
IPC分类号： C12P21/04 , C12Q1/68 , C12N5/06
CPC分类号： A61K39/04 , A61K39/12 , A61K39/145 , A61K48/00 , A61K2039/5256 , A61K2039/53 , A61K2039/55516 , C12N15/86 , C12N2710/10343 , C12N2710/14043 , C12N2710/14143 , C12N2760/16134 , C12N2840/203
摘要： Viral-based vectors are genetically engineered to express inhibitors of the anti-viral immune system (e.g. inhibitors of the type I interferon response) in order to enhance transgene expression. The transgenes may encode antigens or other therapeutic agents.

5. 发明公开

EP1551225A4 CRYOPRESERVATION OF HAPTENIZED TUMOR CELLS 审中-公开
标题翻译：冷冻保存半抗原的肿瘤细胞
公开(公告)号：EP1551225A4
公开(公告)日：2011-05-25
申请号：EP03757476
申请日：2003-06-10
申请人： AVAX TECHNOLOGIES INC , UNIV JEFFERSON
发明人： BERD DAVID , ERDILE LORNE F , MOKYR MARGALIT B
IPC分类号： C12N1/04 , A01N20060101 , A01N1/00 , A01N1/02 , A61K9/19 , A61K35/12 , A61K39/00 , A61K39/39 , A61K47/26 , A61K47/42 , C12N5/06 , C12N5/08
CPC分类号： A01N1/0221 , A01N1/02

6. 发明公开

EP2307045A1 METHODS AND COMPOSITIONS 审中-公开
标题翻译：方法和组合物
公开(公告)号：EP2307045A1
公开(公告)日：2011-04-13
申请号：EP09766134.2
申请日：2009-06-18
申请人： University Court of the University of Edinburgh
发明人： GREGORY, Christopher , POUND, John David , BOURNAZOU, lrini
IPC分类号： A61K38/40 , C12N5/06 , C12N5/08
CPC分类号： A61K38/40 , C12N5/0642 , C12N2501/998
摘要： The invention relates to methods for modulating granulocyte activation and migration, use of such methods in the treatment of diseases and compositions which may be employed in such methods and uses. In particular, the modulation of granulocyte activation/migration is achieved by increasing or decreasing the amount of lactoferrin in the vicinity of said granulocytes.

7. 发明公开

EP2303293A1 METHODS OF TREATING INFLAMMATORY COLON DISEASES 审中-公开
标题翻译：方法炎性肠道疾病的治疗
公开(公告)号：EP2303293A1
公开(公告)日：2011-04-06
申请号：EP09754339.1
申请日：2009-05-26
申请人： Pluristem Ltd.
发明人： MEIRON, Moran
IPC分类号： A61K35/50 , C12N5/06 , A61P37/00
CPC分类号： A61K35/50 , A61K9/0019 , A61K2035/122 , C12N5/0605
摘要： A method of treating ulcerative colitis or Crohn's disease in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of adherent cells from a placenta or adipose tissue, thereby treating the ulcerative colitis of Crohn's disease.

8. 发明公开

EP2236514A4 ARTIFICIAL PEPTIDE AND USE THEREOF 有权
标题翻译：人工肽及其用途
公开(公告)号：EP2236514A4
公开(公告)日：2011-03-30
申请号：EP09704366
申请日：2009-01-23
申请人： TOAGOSEI CO LTD
发明人： YOSHIDA TETSUHIKO , KOBAYASHI NAHOKO , MASUDA JUNICHI
IPC分类号： C07K7/08 , C12N5/00 , C12N5/06
CPC分类号： C07K7/08 , C07K2319/09 , C12N15/625

9. 发明公开

EP2297300A1 GENERATION OF INDUCED PLURIPOTENT STEM (IPS) CELLS 失效
标题翻译：埃策ON ON ON TEN EN EN EN EN）））））））
公开(公告)号：EP2297300A1
公开(公告)日：2011-03-23
申请号：EP09753663.5
申请日：2009-05-26
申请人： Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V.
发明人： KIM, Jeong, Beom , ZAEHRES, Holm , SCHÖLER, Hans, Robert
IPC分类号： C12N5/06
CPC分类号： C12N5/0696 , A61D19/04 , C12N15/85 , C12N15/8509 , C12N15/873 , C12N2501/602 , C12N2501/603 , C12N2501/604 , C12N2501/606 , C12N2502/13 , C12N2506/08 , C12N2506/13 , C12N2510/00 , C12N2799/027 , G01N33/5073
摘要： The present invention relates to a method of generating an induced pluripotent stem (iPS) cell comprising the step of introducing into a target cell one or two coding sequences each giving rise upon transcription to a factor that contributes to the reprogramming of said target cell into an induced pluripotent stem cell and selected from Oct3/4 or a factor belonging to the Myc, Klf and Sox families of factors, wherein the target cell endogenously expresses at least the factors that are not encoded by the coding sequences to be introduced and selected from Oct3/4 or factors belonging to the Myc, Klf and Sox families of factors, and wherein the cell resulting from the introduction of the one or two coding sequences expresses the combination of factor Oct3/4 and at least one factor of each family of factors selected from the group of Myc, Klf and Sox. Furthermore, the present invention relates to an induced pluripotent stem cell generated by the method of the invention and a method of identifying a compound that contributes to the reprogramming of a target cell into an induced pluripotent stem cell. Also, a method of generating a transgenic non-human animal and a composition comprising an iPS cell generated by the method of the present invention for gene therapy, regenerative medicine, cell therapy or drug screening are envisaged.
摘要翻译：本发明涉及产生诱导多能干细胞（iPS）细胞的方法，该方法包括以下步骤：向靶细胞中引入一个或两个编码序列，每个编码序列在转录时引起有助于将所述靶细胞重新编程成为诱导多能干细胞，选自Oct3 / 4或属于Myc，Klf和Sox家族因子的因子，其中目标细胞至少内源性表达至少不被引入并选自Oct3的编码序列编码的因子 / 4或属于Myc，Klf和Sox家族因子的因子，并且其中由引入一个或两个编码序列产生的细胞表达因子Oct3 / 4与所选因子的至少一个因子的组合从Myc，Klf和Sox组。此外，本发明涉及通过本发明的方法产生的诱导多能干细胞和鉴定有助于将靶细胞重编程为诱导多能干细胞的化合物的方法。此外，设想了产生转基因非人动物的方法和包含通过本发明的方法产生的用于基因治疗，再生医学，细胞治疗或药物筛选产生的iPS细胞的组合物。

10. 发明公开

EP2215264A4 PREVENTION AND TREATMENT OF INFLAMMATION AND ORGAN INJURY AFTER ISCHEMIA/REPERFUSION USING MFG-E8 失效
标题翻译：预防和炎症和器官损伤后缺血/再灌注治疗中使用MFG-E8
公开(公告)号：EP2215264A4
公开(公告)日：2011-03-23
申请号：EP08848811
申请日：2008-11-13
申请人： THE FEINSTEIN INST MEDICAL RES
发明人： WANG PING
IPC分类号： C12Q1/68 , C12N5/16 , C12N5/06
CPC分类号： A61K38/37 , A61K38/1808 , C07K14/485

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式